Both in Biotechnology
PharmaCyte Biotech vs Silexion Therapeutics
Over the past year PMCB returned −66.0% and SLXN returned −99.6%; their daily moves had a correlation of 0.19.
PMCB −66.0% SLXN −99.6%Growth of $1, one year, split-adjusted
| Metric | PMCB | SLXN |
|---|---|---|
| Price | $0.3347 | $0.1532 |
| Market cap | $3.6M | $2.2M |
| Today | −2.45% | −7.54% |
| 1 month | −20.1% | −51.9% |
| 6 months | −55.4% | −97.6% |
| Year to date | −53.8% | −99.2% |
| 1 year | −66.1% | −99.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $30.5M | — |
| Dividend yield | — | — |
| Volatility (60d) | 61.5% | 240.6% |
| Short % of float | 0.8% | 3.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).